The tests were performed using the indirect immunoperoxidase assay. Ninety-three per cent of 15 patients with Crohn's disease had IgG antibodies against Chlamydia, compared to 26% in the control group. In the 20 patients with ulcerative colitis, 45% had IgG antibodies against Chlamydia, compared to 10% in the control group. High serum titres ofIgG antibodies were found in most of the patients with inflammatory bowel disease, mainly with Crohn's disease, while weak reactions appeared in most of the controls in which antibodies were detected. These results suggest a high incidence of Chlamydia infection in the studied patients with inflammatory bowel disease, especially in those with Crohn's disease. The possible association between Chlamydia trachomatis and inflammatory bowel disease is discussed.
Introduction
The aetiology and pathogenesis of inflammatory bowel disease (IBD)are still unknown. The possibility that at least part of these diseases could be caused by specific transmissible agents was suggested many years ago'. The eventual association between Crohn's disease and Chlamydia trachomatis was suspected because granuloma and fistula formation are common expressions of both. A few investigations have been made in the past with contradictory resultsv". In the present study we have investigated this possible association by searching for antichlamydial antibodies in the serum of patients diagnosed as IBD and compared the results with healthy controls.
Patients and methods
Serum samples were obtained from 15 patients with Crohn's disease and 20 patients with ulcerative colitis. Patients with Crohn's disease were diagnosed on the basis of characteristic symptomatology, and clinical and radiological findings. The diagnosis of ulcerative colitis was made by radiological, endoscopic and biopsy criteria. Details of age, sex, history, disease activity and medical or surgical treatment were recorded for each patient. Control serum samples were obtained from 35 healthy subjects, who were interviewed to ensure that they represented a healthy population and who were matched for age and sex.
The serum samples were coded and tested blind for the presence of antichlamydial IgG and IgA antibodies using the indirect immunoperoxidase assay ClPAzyme Chlamydia Kit; Savion Diagnostics Ltd, Beer Sheva, Israel). Elevated titres of specific IgG and IgA antibodies can serve as a marker for C. trachomatis present or past infection.
The results achieved in both groups were compared and the statistical significance was assessed by Student's t-test.
Results
Five of 15 patients with Crohn's disease (33%) had IgA antibodies to C. trachomatis, compared to one in the control group (6%). This difference was not statistically significant (P=0.1-0.05, Table 1 ). IgG antibodies were detected in 14 patients with Crohn's disease, (93%)compared to four subjects in the control group (26%)and this difference was clearly significant (P<0.0025, Table 1 ).
In the group with Crohn's disease, the IgG titres were 1/64 in six patients, 1/128 in two, 1/256 in four and 1/1024 in the other two. In the control group, they appeared at level 1/64 in all the positive four individuals.
In the ulcerative colitis group, IgA antibodies were found in one patient and none in the control group, but IgG antibodies were positive in nine patients (45%) and only in two controls (10%). These results were statistically significant (P=O.OI, Table 2 ).
Among the patients with ulcerative colitis, the IgG titres were 1/64 in four, 1/128 in three, and 1/256 in the other two. In the two positive controls, the levels were 1/64 in one, and 1/128 in the other one.
Regarding the IgG antibodies in the whole group of patients with inflammatory bowel disease (Crohn's disease+ulcerative colitis), there were a significant number of positive results (62.8%) when compared to the control group (20%) (P< 0.0005). Furthermore, higher titres were detected among the inflammatory group than in the positive controls.
Discussion
Crohn's disease was first described in 1932 1 and since then, there has been a marked rise in the incidence of the disease which can not be attributed only to genetic or dietary aetiology or to greater recognition of the disease. Aetiology and pathogenesis of ulcerative colitis is obscure and there is substantial evidence suggesting that an environmental transmissible agent may playa role in both diseasesv P. This possibility is also supported by the observation that an IgM lymphocytotoxic antibody, which is present in about half the patients with inflammatory bowel disease, also occurs within those who live close to them at a significantly greater frequency than in controls".
Since Crohn had failed to transmit the disease by injecting tissue homogenate of patients with IBD, to healthy laboratory animals, many pathogens have been suggested as being causatives of IBD: Mycobacterium paratuberculosis, Eubacterium contortum, Peptostreptococcus, Yersinia enterocolitica, Clostridium difficile, Campylobacterjejuni, Bacteroides fragilis, Pseudomonas and others". The search after an infecting agent was encouraged by the similarity between Crohn's disease and other inflammatory diseases of the bowel in men and animals caused by these agents.
We want to focus attention on C. trachomatis. This obligatory intracellular parasite has great invasiveness and affinity for lymphatic tissue and can cause a broad spectrum of systemic and urogenital diseases in men and animals.
There is clinical and histological similarity between Crohn's disease and lymphogranuloma venereum which is caused by C. trachomatis (immunotypes L1, 2 and 3). Indeed this similarity between Crohn's disease and lymphogranuloma venereum, and especially the anorectal version of the disease, enhanced some authors to try to find any aetiologic association between Chlamydia and IBD. Tomenius It was very tempting to suggest that Chlamydia really causes IBD, although these results were not supported by other reports':", As suggested by Elliot et al. 8 , the reasons for the discrepant findings of the various groups of investigators could be due to their testing a different patient population or by variations in performing the test.
Quinn et al.16 were successful in setting up an experimental model of inflammatory bowel disease in monkeys, by inoculating C. trachomatis. The primates developed rectal granulomas identical to those found in Crohn's disease. In calves, oral administration of Chlamydia resulted in infections of the distal ileum and the regional mesenteric lymph nodes-".
In our present investigation we have documented a significantly higher presence of antichlamydial IgG antibodies in patients with inflammatory bowel disease, in comparison to healthy controls. This type of antibody formation suggests long standing antigenic stimulation and, as pointed out by Schuller et al. 2 it is tempting to speculate that Chlamydia may playa role in IBD. A possible explanation is that some patients, clinically misdiagnosed as Crohn's disease or ulcerative colitis, have an underlying chlamydial infection with similar clinical, endoscopic and radiological appearances. Investigation of chlamydial antibodies in the serum must be done in order to establish the correct diagnosis and to define specific therapy. Another explanation is based on the hypothesis that the antichlamydial antibodies in the serum, reflect intestinal invasion secondary to mucosal barriers damaged by the inflammatory process'". James et al. 19 suggested that IBD, and especially Crohn's disease, may be due to an immunoregulatory abnormal response to antigens present in the mucosal environment. In this sense, Chlamydia may act as an aetiologic agent that starts the pathological process that finally results in IBD, or alternatively, may playa role as an aggravating factor in a bowel previously damaged by a noninfectious disease. Women's National Cancer Control Campaign The Women's National Cancer Control Campaign is seeking the services of women doctors nationwide to help with their screening programmes to check for breast and cervical cancer. The Campaign arranges screening programmes at workplaces and town centres, either on the customer's own premises or in the Campaign's mobile units, which are paid for by employers and sponsors. Although much of the screening undertaken by the Campaign is industrial, there are also successful public programmes which help to reach women who might not normally be screened, and ensure that they are now registered on their local Health Authority's recall system. The WNCCC screening programme offers the following services to each woman attending: a cervical smear test; a breast examination by manual palpation; an internal pelvic examination; and basic instruction in breast self examination.
Forthcoming events
There is a constant demand for female doctors with experience in this field. Hence it is essential that we maintain a comprehensive network of female doctors and nurses nationwide, so that staffing the units is made as efficient as possible. Women doctors who are interested in working for the Campaign for even one session (morning or afternoon) in their own areas should contact Rosemary Main at WNCCC, 1 South Audley Street, London WIY 5DQ. (Tel: 01-4997532). Details of pay and conditions are available on application.
